Zimmer Biomet Holdings, Inc. ZBH
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) Free cash flow
Zimmer Biomet Holdings, Inc.'s free cash flow for fiscal 2025 was $1.1B, up 24.1% from $902.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.0B. Over the past ten years it has ranged from $415.7M (fiscal 2015) to $1.3B (fiscal 2018); the current reading is higher than 91% of that period. Zimmer Biomet Holdings, Inc. ranks 10th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $1.1B | 24.09% |
| FY2024 | $902.3M | 3.07% |
| FY2023 | $875.4M | (0.56%) |
| FY2022 | $880.3M | (10.05%) |
| FY2021 | $978.7M | 38.96% |
| FY2020 | $704.3M | (18.60%) |
| FY2019 | $865.2M | (33.87%) |
| FY2018 | $1.3B | 20.11% |
| FY2017 | $1.1B | (1.15%) |
| FY2016 | $1.1B | 165.10% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $246.0M | 18.90% |
| Mar 2026 | $206.9M | (34.50%) |
| Dec 2025 | $315.9M | 18.01% |
| Sep 2025 | $267.7M | 23.02% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.8B |
| GEHC GE HealthCare Technologies Inc. compare | $1.6B |
| ZBH Zimmer Biomet Holdings, Inc. | $1.0B |
| STE STERIS plc compare | $936.0M |
| GMED Globus Medical, Inc. compare | $755.6M |
| BIO Bio-Rad Laboratories, Inc. compare | $353.1M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $353.1M |
| PEN Penumbra, Inc. compare | $215.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ZBH
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement